| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | NEUTRAL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.21▼ | 3.15▼ | 3.15▼ | 3.08▲ | 3.70▼ |
| MA10 | 3.16▼ | 3.14▲ | 3.13▲ | 3.27▼ | 3.86▼ |
| MA20 | 3.15▲ | 3.10▲ | 3.10▲ | 3.75▼ | 3.47▼ |
| MA50 | 3.10▲ | 3.18▼ | 3.27▼ | 4.01▼ | 3.69▼ |
| MA100 | 3.18▼ | 3.70▼ | 3.79▼ | 3.43▼ | 2.94▲ |
| MA200 | 3.59▼ | 3.84▼ | 3.81▼ | 3.54▼ | 2.48▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.006▲ | 0.018▲ | 0.031▲ | -0.100▼ | -0.066▼ |
| RSI | 50.795▲ | 50.471▲ | 47.633▼ | 36.583▼ | 45.988▼ |
| STOCH | 45.228 | 54.443 | 63.532 | 7.137▼ | 26.884 |
| WILL %R | -74.419 | -52.459 | -52.459 | -90.385▼ | -79.643▼ |
| CCI | -16.058 | 42.640 | 57.403 | -57.885 | -156.793▼ |
|
Tuesday, March 03, 2026 09:01 PM
CPIX reports significant revenue growth and global expansion, while navigating increased expenses and financial commitments.
|
|
Tuesday, March 03, 2026 04:04 PM
Cumberland Pharmaceuticals (NASDAQ:CPIX) reported fourth-quarter and full-year 2025 results and provided a business update during its earnings call, highlighting revenue growth across its portfolio, ...
|
|
Tuesday, March 03, 2026 03:33 PM
Kazimi stated, "As we look ahead, we're once again targeting double-digit revenue growth in 2026, driven by the continued performance of our in-line brands combined with the additional sales from the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/03/26 | 3.31 | 3.31 | 3.15 | 3.15 | 25,417 |
| 16/03/26 | 3.03 | 3.18 | 3.03 | 3.06 | 28,774 |
| 13/03/26 | 3.095 | 3.14 | 2.95 | 3.04 | 65,398 |
| 12/03/26 | 3.02 | 3.12 | 3.02 | 3.09 | 50,247 |
| 11/03/26 | 3.33 | 3.33 | 3.03 | 3.08 | 129,589 |
| 10/03/26 | 3.3745 | 3.392 | 3.15 | 3.16 | 55,514 |
| 09/03/26 | 3.44 | 3.552 | 3.30 | 3.41 | 131,402 |
| 06/03/26 | 3.49 | 3.59 | 3.37 | 3.50 | 52,104 |
| 05/03/26 | 3.67 | 3.76 | 3.51 | 3.52 | 91,855 |
| 04/03/26 | 4.58 | 4.58 | 3.63 | 3.67 | 509,606 |
|
|
||||
|
|
||||
|
|